Impact of 99mTc-GSA SPECT Image-Guided Inverse Planning on Dose-Function Histogram Parameters for Stereotactic Body Radiation Therapy Planning for Patients With Hepatocellular Carcinoma: A Dosimetric Comparison Study
- PMID: 30858770
- PMCID: PMC6402061
- DOI: 10.1177/1559325819832149
Impact of 99mTc-GSA SPECT Image-Guided Inverse Planning on Dose-Function Histogram Parameters for Stereotactic Body Radiation Therapy Planning for Patients With Hepatocellular Carcinoma: A Dosimetric Comparison Study
Abstract
Purpose: To evaluate the impact of 99mTc-labeled diethylene triamine pentaacetate-galactosyl human serum albumin (99mTc-GSA) single-photon emission computed tomography (SPECT) image-guided inverse planning on the dose-function histogram (DFH) parameters for stereotactic body radiation therapy planning in patients with hepatocellular carcinoma (HCC).
Methods: Eleven patients were enrolled in this study. The functional liver structure (FLS) was derived from SPECT thresholds of 60% to 80% of the maximum pixel value. Two treatment plans optimized without FLS (plan C) and with FLS (plan F) were designed for 50 Gy to the planning target volume (PTV). The DFH parameters were calculated as follows: Fx = (sum of the counts within the liver volume receiving a dose >x Gy/sum of the counts within the whole liver volume) × 100. Other parameters for the PTV included D95, mean dose, conformity index (CI), and homogeneity index (HI).
Results: Compared with plan C, plan F significantly reduced DFH parameters of F5 to F40 (P < .05). There were no significant differences in the parameters of the PTV of D95, mean dose, CI, and HI and organs at risks (stomach, duodenum, spinal cord, and kidneys) between plans C and F.
Conclusion: DFH analyses revealed that 99mTc-GSA SPECT image-guided inverse planning provided dosimetric benefits related to sparing of liver function and may reduce hepatic toxicities.
Keywords: dose–function histogram; dose–volume histogram; hepatocellular carcinoma; molecular imaging; radiation-induced liver disease; stereotactic body radiation therapy.
Conflict of interest statement
Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures

Similar articles
-
Stereotactic Body Radiotherapy Based on 99mTc-GSA SPECT Image-guided Inverse Planning for Hepatocellular Carcinoma.In Vivo. 2020 Nov-Dec;34(6):3583-3588. doi: 10.21873/invivo.12202. In Vivo. 2020. PMID: 33144471 Free PMC article.
-
Dose-function Histogram Evaluation Using 99mTc-GSA SPECT/CT Images for Stereotactic Body Radiation Therapy Planning for Hepatocellular Carcinoma Patients: A Dosimetric Parameter Comparison.Anticancer Res. 2018 Mar;38(3):1511-1516. doi: 10.21873/anticanres.12378. Anticancer Res. 2018. PMID: 29491079
-
Functional image-guided stereotactic body radiation therapy planning for patients with hepatocellular carcinoma.Med Dosim. 2017 Summer;42(2):97-103. doi: 10.1016/j.meddos.2017.01.005. Epub 2017 Apr 19. Med Dosim. 2017. PMID: 28433483 Clinical Trial.
-
Incorporating GSA-SPECT into CT-based dose-volume histograms for advanced hepatocellular carcinoma radiotherapy.World J Radiol. 2014 Aug 28;6(8):598-606. doi: 10.4329/wjr.v6.i8.598. World J Radiol. 2014. PMID: 25170397 Free PMC article. Review.
-
A review on functional lung avoidance radiotherapy plan for lung cancer.Front Oncol. 2024 Dec 5;14:1429837. doi: 10.3389/fonc.2024.1429837. eCollection 2024. Front Oncol. 2024. PMID: 39703855 Free PMC article. Review.
Cited by
-
Validation study on accuracy of our newly proposed methods for post-therapeutic liver reserve capacity estimation utilizing 99 mTc-GSA scintigraphy prior to carbon-ion radiotherapy.Ann Nucl Med. 2025 Aug;39(8):781-791. doi: 10.1007/s12149-025-02048-1. Epub 2025 Apr 28. Ann Nucl Med. 2025. PMID: 40293691
-
Stereotactic Body Radiotherapy Based on 99mTc-GSA SPECT Image-guided Inverse Planning for Hepatocellular Carcinoma.In Vivo. 2020 Nov-Dec;34(6):3583-3588. doi: 10.21873/invivo.12202. In Vivo. 2020. PMID: 33144471 Free PMC article.
-
Phase I trial of single-photon emission computed tomography-guided liver-directed radiotherapy for patients with low functional liver volume.JNCI Cancer Spectr. 2024 Apr 30;8(3):pkae037. doi: 10.1093/jncics/pkae037. JNCI Cancer Spectr. 2024. PMID: 38730548 Free PMC article. Clinical Trial.
-
Proteomic Analysis of Radiation-Induced Acute Liver Damage in a Rabbit Model.Dose Response. 2019 Nov 29;17(4):1559325819889508. doi: 10.1177/1559325819889508. eCollection 2019 Oct-Dec. Dose Response. 2019. PMID: 31827415 Free PMC article.
-
Functional Liver Imaging in Radiotherapy for Liver Cancer: A Systematic Review and Meta-Analysis.Front Oncol. 2022 Jun 17;12:898435. doi: 10.3389/fonc.2022.898435. eCollection 2022. Front Oncol. 2022. PMID: 35785217 Free PMC article.
References
-
- Klein J, Dawson LA. Hepatocellular carcinoma radiation therapy: review of evidence and future opportunities. Int J Radiat Oncol Biol Phys. 2013;87(1):22–32. - PubMed
-
- Seo YS, Kim MS, Yoo SY, et al. Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma. J Surg Oncol. 2010;102(3):209–214. - PubMed
-
- Andolino DL, Johnson CS, Maluccio M, et al. Stereotactic body radiotherapy for primary hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2011;81(4):e447–e453. - PubMed
-
- Sanuki N, Takeda A, Oku Y, et al. Stereotactic body radiotherapy for small hepatocellular carcinoma: a retrospective outcome analysis in 185 patients. Acta Oncol. 2014;53(3):399–404. - PubMed
-
- Toya R, Murakami R, Baba Y, et al. Conformal radiation therapy for portal vein tumor thrombosis of hepatocellular carcinoma. Radiother Oncol. 2007;84(3):266–271. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous